Assessing the clinical significance of change scores recorded on subjective outcome measures

Guyatt, 1998, Interpreting treatment effects in randomized trials, Br Med J, 316, 690, 10.1136/bmj.316.7132.690

Sackett DL, Straus SE, Richardson WS, Rosenberg W, Haynes RB. Evidence-based medicine. London: Churchill Livingstone; 2000. p. 105-53

Turk, 2000, Statistical significance and clinical significance are not synonyms!, Clin J Pain, 16, 185, 10.1097/00002508-200009000-00001

Wyrwich, 2000, Identifying meaningful intra-individual change standards for health-related quality of life measures, J Eval Clin Pract, 6, 39, 10.1046/j.1365-2753.2000.00238.x

Middel, 2001, How to validate clinically important change in health-related functional status. Is the magnitude of the effect size consistently related to magnitude of change as indicated by a global question rating?, J Eval Clin Pract, 7, 399, 10.1046/j.1365-2753.2001.00298.x

Cohen J. Statistical power analysis for the behavioural sciences. New York: Academic Press; 1977

Testa, 1987, Interpreting quality of life clinical trial data for use in the clinical practice of antihypertensive therapy, J Hypertens Suppl, 5, S9

Jacobson, 1984, Psychotherapy outcome research, Behav Ther, 15, 336, 10.1016/S0005-7894(84)80002-7

Christensen, 1986, A method of assessing change in a single subject, Behav Ther, 17, 305, 10.1016/S0005-7894(86)80060-0

Wyrwich, 1999, Linking clinical relevance and statistical significance in evaluating intra-individual changes in health-related quality of life, Med Care, 37, 469, 10.1097/00005650-199905000-00006

Farrar, 2001, Clinical importance of changes in chronic pain intensity measured on an 11-point numerical rating scale, Pain, 94, 149, 10.1016/S0304-3959(01)00349-9

Rowbotham, 2001, What is a ‘clinically meaningful’ reduction in pain?, Pain, 94, 131, 10.1016/S0304-3959(01)00371-2

Deyo, 1986, Assessing the responsiveness of functional scales to clinical change, J Chronic Dis, 39, 897, 10.1016/0021-9681(86)90038-X

Bolton, 1999, The Bournemouth Questionnaire, J Manipulative Physiol Ther, 22, 503, 10.1016/S0161-4754(99)70001-1

Bolton, 2001, The Bournemouth Questionnaire, J Manipulative Physiol Ther, 25, 141, 10.1067/mmt.2002.123333

Turk, 1998, Interdisciplinary treatment for fibromyalgia syndrome, Arthritis Care Res, 11, 186, 10.1002/art.1790110306

Kazis, 1989, Effect sizes for interpreting changes in health status, Med Care, 27, S178, 10.1097/00005650-198903001-00015

Little, 1994, The use of the percentage change in Oswestry Disability Index score as an outcome measure in lumbar spinal surgery, Spine, 19, 2139, 10.1097/00007632-199410000-00001

Farrar, 2000, Defining the clinically important difference in pain outcome measures, Pain, 88, 287, 10.1016/S0304-3959(00)00339-0

Sackett DL, Straus SE, Richardson WS, Rosenberg W, Haynes RB. Evidence-based medicine. London: Churchill Livingstone; 2000. p. 67-93

Jaeschke, 1989, Measurement of health status, Control Clin Trials, 10, 407, 10.1016/0197-2456(89)90005-6

Juniper, 1994, Determining a minimal important change in a disease-specific quality of life questionnaire, J Clin Epidemiol, 47, 81, 10.1016/0895-4356(94)90036-1

Beurskens, 1996, Responsiveness of functional status in low back pain, Pain, 65, 71, 10.1016/0304-3959(95)00149-2

Lijmer, 1999, Empirical evidence of design-related bias in studies of diagnostic tests, JAMA, 282, 1061, 10.1001/jama.282.11.1061